Correlation Between Novolog Pharm and Kamada

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novolog Pharm and Kamada at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novolog Pharm and Kamada into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novolog Pharm Up 1966 and Kamada, you can compare the effects of market volatilities on Novolog Pharm and Kamada and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novolog Pharm with a short position of Kamada. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novolog Pharm and Kamada.

Diversification Opportunities for Novolog Pharm and Kamada

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Novolog and Kamada is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Novolog Pharm Up 1966 and Kamada in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kamada and Novolog Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novolog Pharm Up 1966 are associated (or correlated) with Kamada. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kamada has no effect on the direction of Novolog Pharm i.e., Novolog Pharm and Kamada go up and down completely randomly.

Pair Corralation between Novolog Pharm and Kamada

Assuming the 90 days trading horizon Novolog Pharm Up 1966 is expected to generate 0.96 times more return on investment than Kamada. However, Novolog Pharm Up 1966 is 1.04 times less risky than Kamada. It trades about 0.07 of its potential returns per unit of risk. Kamada is currently generating about 0.05 per unit of risk. If you would invest  12,940  in Novolog Pharm Up 1966 on September 15, 2024 and sell it today you would earn a total of  4,050  from holding Novolog Pharm Up 1966 or generate 31.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Novolog Pharm Up 1966  vs.  Kamada

 Performance 
       Timeline  
Novolog Pharm Up 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Novolog Pharm Up 1966 are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Novolog Pharm sustained solid returns over the last few months and may actually be approaching a breakup point.
Kamada 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kamada are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kamada may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Novolog Pharm and Kamada Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novolog Pharm and Kamada

The main advantage of trading using opposite Novolog Pharm and Kamada positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novolog Pharm position performs unexpectedly, Kamada can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kamada will offset losses from the drop in Kamada's long position.
The idea behind Novolog Pharm Up 1966 and Kamada pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk